Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has reported an abnormal price rise in its shares, which was not supported by any corporate announcements or material changes in the business activities of the company. The company has observed unusual trades in its shares, with only one equity share being traded and the share price increasing significantly. The company has requested the BSE to examine the transactions and investigate possible price rigging.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has published a newspaper advertisement for standalone un-audited financial results for the quarter ended June 30, 2026, as per SEBI (LODR) Regulations, 2015.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has announced the 31st Annual General Meeting (AGM) of the company, with a cut-off date for voting and e-voting as per SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has announced a notice of book closure as per Regulation 42 of the SEBI (Listing Obligations and Disclosures Requirements [LODR]), Regulations, 2015 for the purpose of 31st Annual General Meeting (e-AGM) to be held on September 28, 2026.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has announced the re-appointment of Anuradha Kashikar as an Executive Director for another term of three consecutive years commencing from April 1, 2027.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has announced the resignation of Anuradha Kashikar as Chief Financial Officer (CFO) and the appointment of Sapna Mhatre as the new CFO, effective August 14, 2026.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has appointed M/s. Utsav Shah & Associates as its Internal Auditor for the Financial Year 2026-2027, as per the requirements of the Companies Act 2013 and SEBI (LODR) Regulations, 2015.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has approved its standalone un-audited financial results for the quarter ended June 30, 2026, and submitted the documents to BSE Limited.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd's Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, August 14, 2026. The Board approved the standalone un-audited financial results for the quarter ended June 30, 2026, and re-appointed Ms. Anuradha Kashikar as Executive Director for a period of three years. Ms. Kashikar also resigned as Chief Financial Officer, and Ms. Sapna Mhatre was appointed as the new Chief Financial Officer. The Board also appointed M/s. Utsav Shah & Associates as Internal Auditors for the Financial Year 2026-2027.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve standalone un-audited financial results for the quarter ended June 30, 2026, along with other business.

Centenial Surgical Suture Ltd

Centenial Surgical Suture Ltd announced the closure of its trading window for all designated persons, effective from July 1, 2026. This measure is in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed until 48 hours after the financial results for the quarter ended June 30, 2026, are publicly disseminated to the stock exchange. This is a standard procedural announcement.